Global Diabetes Drugs Market

With a valuation of US$ XX Mn in 2016 which is expected to reach US$ XX Mn by 2022 and a Compounded Annual Growth rate of XX%, the Global Diabetes Drugs Market is increasing at a steady pace. Diabetes is a medical condition where the sugar level in the blood is high. Diabetes Drugs are used to treat this condition. They do so by controlling the glucose level in the blood. The type of anti-diabetic drug that must be used depends on the type of diabetes in the patient. For type 1 diabetes insulin must be used with this type of diabetes is caused by the lack of insulin. Whereas for type 2 diabetes which is a more common type of diabetes there is an insulin resistance shown by the cells. For type 2 diabetes the drugs are mostly administered orally. This kind of drugs is called oral hypoglycemic agents or oral anti-hyperglycemic agents.

Market Dynamics

The factors that drive growth for the Diabetes Drugs Market include ever-increasing diabetic population and the technological innovations happening in the field. The stringent regulatory procedures are a major challenge for this industry. Another challenge for this industry is the-the large amount of time taken for the approval process

The market also throws up several opportunities with regard to the increasing adoption rate of these drugs in developing regions.

Market Segmentation

The market is segmented in terms of the type, application, and geography.

In terms of the type, the market is classified into injectable and oral drugs. Insulin, Exenatide, Liraglutide, and Pramlintide are the types of injectable drugs. Biguanides, Sulfonylureas, Meglitinides and D-Phenylalanine Derivatives, Thiazolidinediones, DPP-4 Inhibitors, Alpha-glucosidase Inhibitors, Bile Acid Sequestrants are the common types of oral drugs.

In terms of application, the market is segmented into type 1 and type 2. Type 1 drugs are used to treat type 1 diabetes which is caused by the lack of insulin. Type 2 drugs are used to treat type 2 diabetes which is caused by the insulin resistance of the cells.

The different geographic market segments are North America, Europe, Asia Pacific and Rest of the world.

Regional/Geographic Analysis

North America is the dominating market in terms of market share due to the increasing diabetic population. North America is followed by Europe in terms of market share. But in terms of growth rate, Asia Pacific is the expected to be the leader because of the developing infrastructure and increased public health awareness.

Key Players

Some of the major players in the market include Bayer, Biocon, GlaxoSmithKline (GSK), Merck & Co, Novartis, Sanofi, Sun Pharma, Zydus Cadila.

The report contains comprehensive analysis on:

Global Diabetes Drugs Market Segments

Global Diabetes Drugs Market Drivers, Restraints and Opportunities

Global Diabetes Drugs Market Size & Forecast 2016 to 2022

Supply & Demand Value Chain

Global Diabetes Drugs Market Current Trends

Competition & Major Companies

Technology and R&D Status

Porters Five Force Analysis

Strategic and Critical Success Factor Analysis of Key Players

Regional analysis for Global Diabetes Drugs Market includes

--> North America

>> US and Canada

--> Latin America

>> Mexico, Brazil, Argentina and Rest of Latin America

--> Western Europe

>> EU5 (Germany, France, Italy, Spain, U.K.)

>> Nordic Countries (Denmark, Finland, Norway, and Sweden)

>> Benelux (Belgium, The Netherlands, and Luxembourg)

>> Rest of Western Europe

--> Eastern Europe

>> Russia

>> Poland

>> Rest of Eastern Europe

--> Asia Pacific

>> China

>> India

>> Japan

>> Australia and New Zealand

>> Rest of Asia Pacific

--> Middle East and Africa

>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)

>> South Africa

>> North Africa

>> Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides in-depth market segmentation that is derived from extensive product mapping exercises, macro-economic factors and other qualitative and quantitative insights. The impact of all such factors are delivered across multiple market segments and geographies.

Report Highlights::

--> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)

--> Consumer and Pricing Analysis

--> Market dynamics of the industry

--> In-depth Market Segmentation

--> Historical and Projected Market Sizing in terms of volume and value

--> Recent market trends and Impact Factors

--> R&D Status and Technology Overview

--> Extensive Industry Structure Coverage